Skip to main content

MOORE CAPITAL MANAGEMENT, LP

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1448574 NEW YORK, NY

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,165,713
+$3,120,711 QoQ
Shares Held
75,588
+69.1% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#90
of 380 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Derivatives in PTCT

reported options exposure · as of Sep 30, 2023
CallValue
$683,505
CallShares
30,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names. PTCT ranks #7 (4.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 PTCT
Ptc Therapeutics, Inc.
This page
75,588 $6,165,713

All Filings in PTCT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,165,713 75,588
2026-03-31 $3,045,002 44,694
2023-09-30 $683,505 30,500
2023-06-30 $1,016,750 25,000
2023-03-31 $1,380,540 28,500
2022-12-31 $1,145,100 30,000
2022-09-30 $1,004,000 20,000
2022-06-30 $1,602,400 40,000
2022-03-31 $1,492,400 40,000
2021-12-31 $1,593,200 40,000
2021-09-30 $1,488,400 40,000
2021-06-30 $1,690,800 40,000
2021-03-31 $1,894,000 40,000
2020-12-31 $2,537,139 41,572
2020-09-30 $2,337,500 50,000
2020-06-30 $2,029,600 40,000
2020-03-31 $1,784,400 40,000